Pages that link to "Q80656635"
Jump to navigation
Jump to search
The following pages link to Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells (Q80656635):
Displaying 50 items.
- Optimization of cardiac metabolism in heart failure (Q27023021) (← links)
- Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity (Q27302419) (← links)
- Renin‐Angiotensin‐Aldosterone System in Diabetes and Hypertension (Q28308222) (← links)
- Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor (Q28573063) (← links)
- Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population (Q28742792) (← links)
- Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension (Q33667283) (← links)
- Skeletal muscle insulin resistance in endocrine disease (Q33734293) (← links)
- Aldosterone: role in the cardiometabolic syndrome and resistant hypertension (Q33736838) (← links)
- The effects of the renin-angiotensin-aldosterone system gene polymorphisms on insulin resistance in hypertensive families (Q33951289) (← links)
- Aldosterone Enhances IGF-I-Mediated Signaling and Biological Function in Vascular Smooth Muscle Cells (Q34392644) (← links)
- The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes. (Q34409899) (← links)
- Effects of aldosterone on insulin sensitivity and secretion (Q34614820) (← links)
- A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy (Q35025285) (← links)
- Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney (Q35026645) (← links)
- PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates (Q35055601) (← links)
- Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome (Q35113885) (← links)
- Central regulation of blood pressure by the mineralocorticoid receptor (Q35293123) (← links)
- Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males (Q35490517) (← links)
- Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. (Q35551235) (← links)
- RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients (Q35916560) (← links)
- Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients (Q36106582) (← links)
- Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations (Q36297722) (← links)
- Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? (Q36560643) (← links)
- Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects. (Q36665733) (← links)
- Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. (Q36674142) (← links)
- Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. (Q36805476) (← links)
- Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up (Q36836343) (← links)
- Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum (Q37126967) (← links)
- Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat. (Q37190283) (← links)
- Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression. (Q37210815) (← links)
- The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update (Q37215435) (← links)
- Obesity, sleep apnea, aldosterone, and hypertension (Q37258828) (← links)
- Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines (Q37352865) (← links)
- Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids (Q37575390) (← links)
- Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems (Q37592161) (← links)
- Aldosterone and arterial hypertension (Q37660912) (← links)
- New insights into insulin action and resistance in the vasculature (Q37707789) (← links)
- Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice via ameliorating inflammation (Q37727721) (← links)
- Advances in pharmacologic modulation of nitric oxide in hypertension (Q37784448) (← links)
- The Role of Aldosterone in the Metabolic Syndrome (Q37833554) (← links)
- The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy (Q38374536) (← links)
- Targeting inflammation in metabolic syndrome. (Q38553529) (← links)
- Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells (Q38870573) (← links)
- High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells (Q41627673) (← links)
- Aldosterone aggravates glucose intolerance induced by high fructose (Q41848157) (← links)
- Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation (Q42317371) (← links)
- Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome (Q42759679) (← links)
- Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation (Q43116242) (← links)
- Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV. (Q53695087) (← links)
- The Vasculature in Prediabetes. (Q53695913) (← links)